Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
84 participants
INTERVENTIONAL
2022-02-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: The study is conducted as a Randomized Controlled Study. Method: Heel protectors will be used in the intervention group among the patients in the intensive care unit who meet the inclusion criteria of the study, and the control group will be positioned with a pillow, which is the standard practice. As calculated in the G-Power program with reference to the source, a total of 42 patients were determined to be included in the intervention group and 42 patients in the control group. These patients will be followed for a total of 14 days. Heel Scalp Evaluation and Goniometric Measurements will be made according to Braden Pressure Wound Risk Assessment Scale, Ramsey Sedation Scale, NPUAP and EPUAP Staging System and recorded in the data collection form created by the researcher.
H1: The heel protector is effective in preventing heel pressure ulcer. H0: The heel protector has no effect on preventing heel pressure ulcer. H2: The heel protector is effective in preventing plantar flexion contracture. H0: The heel protector has no effect on preventing plantar flexion contracture. H3: The heel protector is effective in improving the joint range of patients with plantar flexion contracture.
H0: The heel protector has no effect on improving joint range in patients with plantar flexion contracture.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
NCT06238791
An Analysis of Plantar Pressure Distribution and Postural Balance Parameters in Individuals With Diabetic Foot Diagnosis
NCT07084922
Balance, Plantar Pressure Distribution and Gait in Pes Planus
NCT05240287
Effectiveness of Strengthening Exercise Program Compare With Foot Orthoses in Patients With Plantar Heel Pain
NCT05059054
Investigation of the Relationship Between Plantar Foot Pressure and Balance in Morbidly Obese Individuals
NCT05519436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EHepIcu
The Effect Of Heel Protector In Intensive Care Units
In the experimental group, foot joint opening and heel pressure sore formation will be observed by using heel protector pad.
Control group
Heel pads will not be used in the control group. Routine maintenance will be applied
Control Grubs
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The Effect Of Heel Protector In Intensive Care Units
In the experimental group, foot joint opening and heel pressure sore formation will be observed by using heel protector pad.
Control group
Heel pads will not be used in the control group. Routine maintenance will be applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with Braden Pressure Sore Risk Assessment Scale 16 and below
* Patients with a Ramsey Sedation Scale of 4 and above
Exclusion Criteria
* Patients with vascular disease
* Patients with albumin level below 2.5 mg/dL
* Patients mobile within 5 days
* Patients hospitalized with heel pressure ulcer
* Despite being included in the study, the patient becomes mobile before 15 days
* Patients with a medical condition that contraindicates the use of heel protectors
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maltepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kübra Arslan
Master's Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebahat Ateş
Role: STUDY_DIRECTOR
Üsküdar Üniversitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kübra Arslan
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/33-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.